Professional Documents
Culture Documents
State of Pregnancy Modifies Lead
State of Pregnancy Modifies Lead
ABSTRACT
Toxicity of lead acetate after administration through the oral
route at 0-50 m g / k g body weight of animal has been assessed in the
liver of pregnant mice and compared with the effect in the liver of
nonpregnant dams. Analysis showed that the basal level of hepatic
lead is considerably reduced during pregnancy as compared to that
in nonpregnant state. After administration of Pb-acetate, deposited
lead in liver of nonpregnant mice was 3- to 4-fold while in pregnant
mice was, it was 1.8- to 3.0-fold over their respective control values.
Although hepatic Fe, Cu, and Zn levels had a tendency to be lowered
during pregnancy, it appeared that the added trace quantity of lead
prior to and during pregnancy helped in the retention of these met-
als, which either remained unaffected (as Fe) or declined (Cu and Zn)
after lead administration during the nonpregnant state. The effect
of lead on Mn diminution, however, was visible at the dose of
50 m g / k g body wt of lead-acetate. Alkaline phosphatase, which
increased during pregnancy along with Mn, was reversed between
the pregnant and nonpregnant states after oral administration of
lead. On the other hand, the level of 5-aminolevolunic acid dehy-
dratase, which declined during normal pregnancy, continued to fall
further after lead exposure. It is concluded that the distribution of
basal or administered lead and its effect on enzyme activities and
trace metal composition in liver depends on the pregnant and non-
pregnant states of female hosts.
Index Entries: Lead toxicity; trace metals; hepatic enzymes;
hepatic lead; pregnancy.
INTRODUCTION
Elemental Analysis
One hundred milligrams of lyophilized tissue was digested in 5 mL
of digestion mixture in Corning tubes (AR nitric acid + AR perchloric
Alkaline Phosphatase
Alkaline phosphatase (AP) activity was assayed according to the
method reported earlier (6). One milliliter of p-nitrophenyl phosphate (Na
salt) was incubated in glycine buffer (0.05M, pH 10.5) for 15 rain at 37~
having 0.1 mL of suitable diluted enzyme. After incubation, the reaction
was terminated by 5 mL 0.1N NaOH. The color of p-nitrophenol was mea-
sured at 420 nm. A unit of enzyme was defined as the amount of protein
that liberated 1 Mmol p-nitrophenol/g dry wt of tissue/rain at 37~
Statistics
The significance of changes between two groups was tested by the
Student's t-test, whereas the coefficient of correlation (r) between two
parameters among all the groups of pregnant or nonpregnant mice was
tested by a direct method without taking deviations of items from the
actual mean or the assumed mean. The direction of change of averages
was evaluated by the trend test across the dose of lead-acetate of various
groups by a least squares fit. The coefficients of correlation of these best-
fit lines are given where felt necessary.
RESULTS
Table 1
Effect of Pb-Acetate on Trace Elements of Liver and its Modification by
State of Pregnancy (Values are mean _+fiE)
Dose* Pb Fe Zn Cu Mn
1"0,
A C
~2.o J
C 1.6
0.6'
._>
q 0-4.
o~ , oy
o Io 2o 40 so ; 6 20 3; 4? 50
D
~ 0.4 6.0.
0.2 ,~ ~.o. -4
0~ ,3"
o lo 20 ;o 0 10 20 30 40 50
Pb-ocetote (mg/kg b.wt.) Pb-ocetote ( m g / k g b.wt.)
DISCUSSION
In the present study, hepatic toxicity resulting from lead during the
pregnant and nonpregnant states has been assessed and compared. Dur-
ing pregnancy, the burden of hepatic Pb is considerably reduced and this
continued to be so even after gastric intubation of Pb-acetate. Although
the placenta has a tendency to retard Pb (3), the lead content of fetuses
increases throughout pregnancy. It is stated that the stored lead is mobi-
lized during pregnancy and transferred to the fetus (2,6,9). Part of the
reduced level of lead in body tissues during pregnancy in comparison to
nonpregnant state could, however, be due to the greater fluid intake and,
hence, greater excretion. Nevertheless, it appears that an added trace
quantity of lead in liver during pregnancy helps in the retention of
hepatic Fe, Zn, and Cu, which was evident from their P/NP, NPe/NP0,
and Pe/P0 ratios.
The present study revealed that oral administration of Pb disturbs
liver functions, depending on the accumulated Pb in pregnant and non-
pregnant conditions. Although limited information is available on the
influence of pregnancy-associated proteins and hormonal changes (10) in
the disposition and toxicity of lead, nutritional and endocrine factors
seem to play an important role during Pb exposure, influencing its
absorption and toxic manifestations (7,8). In fact, pregnant mice per se did
not suggest any effect of lead on the levels of Cu and Zn over their
untreated controls, whereas nonpregnant mice showed a decrease of
these metals, as suggested in early investigations (11,12) without a
change in Fe composition during pregnancy or otherwise. Very often,
deficiencies of Cu and Mn have been related to the lipid peroxidation of
membranes and formation of free radicals in proteins (13,14), where glu-
tathione is known to play a role in the defense of cell injury (3,6,14). In
contrast to observations in the kidney and placenta (3,6), the influence of
a low dose of Pb on the enhancement of hepatic Mn was followed by a
decline at the higher dose of the pollutant. Probably the most studied
effect of lead toxicity is related to the inhibition of heme synthesis due to
inhibition of 8-ALAD (6,15,16) and accumulation of 8-aminolevulinic
acid (8-ALA) (17,18). The autooxidation of 8-ALA and other mechanisms
within hepatocytes may form oxygen radicals and other oxidative radi-
cal species, which induces cellular damage (13,19,20).
However, in the absence of Zn loss during the pregnant state, the
question to be addressed is how 8-ALAD, a zinc metalloenzyme, is lost
after Pb toxicity. Possibly, the low sensitivity of hepatic 8-ALAD in com-
parison to kidney and blood (6) after lead exposure depends on the endo-
geneous Pb level and detoxifying mechanisms as well as the replacement
REFERENCES
1. N. E Angell and J. P. Lavery, The relationship of lead levels to obstetric outcome,
Am. ]. Obstet. Gynecol. 14, 4 0 4 6 (1982).
2. J. P. Buchet, R. Lauwerys, H. Roels, and G. Hubermont, Mobilization of lead during
pregnancy in rats, Int. Arch. Occup. Environ. Health 40, 33-36 (1977).
3. G. S. Gupta, J. Singh, and A. Gupta, Trace metals and metalloenzymes in placenta
after oral administration of lead acetate, Biol. Trace Element Res. 60, 145-152 (1997).
4. R. M. McClain and B. A. Becker, Teratogenicity, fetal toxicity and the placental trans-
fer of lead nitrate in rats, Toxicol. Appl. Pharmacol. 31, 443451 (1975).
5. S. Kaur, Lead and cadmium in maternal blood, umbilical cord blood, amniotic fluid
and placenta of cows and buffaloes after fetal death (abortion) and after normal par-
turition, Sci. Total Environ. 19, 2987-2900 (1989).
6. G. S. Gupta, J. Singh, and P. Prakash, Renal toxoicity after oral administration of lead
acetate during pre- and post-implantation periods: effects on trace metal composi-
tion, metalloenzymes and glutathione. Pharmacol. Toxicol. 76, 206-211 (1995).
7. E. M. Sierra and E. Tiffnay-Castiglioni, Effects of low level lead exposure on hypo-
thalamic hormones and serum progesterone levels in pregnant guinea pigs, Toxicol-
ogy 72, 89-97 (1992).
8. G. Singh, D. K. Saxena, R. C. Murthy, and V. Chandra, Embryo fetal development
influenced by lead exposure in iron deficient rats, Human Exp. Toxicol. 12, 25-28 (1993).
9. C. B. Ernhart, A. W. Wolf, R. J. Sokol, G. M. Brittenham, and P. Erhard, Fetal lead
exposure, antenatal factors, Environ. Res. 38, 54-66 (1985).
10. S. W. Rosen, New placental proteins: chemistry, physiology and clinical use, Placenta
7, 575-594 (1986).
11. D. S. Klauder and H. G. Petering, Anemia of lead intoxication, a role of copper,
]. Nutr. 107, 1779-1785 (1977).